SONOMA PHARMACEUTICALS, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
SONOMA PHARMACEUTICALS, INC. (SNOA) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $130.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2023-11-13
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-09-30 was $130.00K, a 20.37% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2023-06-30 was $177.00K, a 17.29% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-12-31 was $233.00K, a 316.07% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2022-09-30 was $108.00K, a 107.69% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $649.00K, a 74.46% increase from fiscal 2022.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $372.00K, a 12.05% increase from fiscal 2021.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2021 was $332.00K.
- SONOMA PHARMACEUTICALS, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2016 was $1.96M, a 10.62% increase from fiscal 2015.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2023-09-30 | $130.00K 10-Q · filed 2023-11-13 | $307.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2023-06-30 | $177.00K 10-Q · filed 2023-11-13 | |||
| 2023-03-31 | $649.00K 10-K · filed 2023-06-21 | |||
| 2022-12-31 | $233.00K 10-Q · filed 2023-02-14 | $341.00K derived: sum of 2 quarters · filed 2023-11-13 | $555.00K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-09-30 | $108.00K 10-Q · filed 2023-11-13 | $322.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $214.00K 10-Q · filed 2023-11-13 | |||
| 2022-03-31 | $372.00K 10-K · filed 2023-06-21 | |||
| 2021-12-31 | $56.00K 10-Q · filed 2023-02-14 | $108.00K derived: sum of 2 quarters · filed 2023-02-14 | $164.00K derived: sum of 3 quarters · filed 2023-02-14 | |
| 2021-09-30 | $52.00K 10-Q · filed 2023-02-14 | $108.00K derived: sum of 2 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $56.00K 10-Q · filed 2023-02-14 | |||
| 2021-03-31 | $332.00K 10-K · filed 2022-07-13 | |||
| 2020-12-31 | $90.00K 10-Q · filed 2021-02-16 | |||
| 2016-03-31 | $1.96M 10-K · filed 2016-06-21 | |||
| 2015-03-31 | $1.77M 10-K · filed 2016-06-21 | |||
| 2014-03-31 | $1.11M 10-K · filed 2015-06-16 | |||
| 2013-03-31 | $1.15M 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |